Sarasota, FL (PRWEB) October 24, 2007
Last week Dr. Stoneburner, from Phototherapyforherpes, announced an interest in conducting clinical trials to test a treatment that reported unofficial results of testing negative for HSV2. Today, Dr. Stoneburner has now obtained a major American Laboratory to assist in "Pre and "Post" ELISA tests. Dr. Stoneburner says "We have obtained the funds to provide pre and post ELISA testing for HSV 2 patients." To register for this free testing one needs to visit the web site at Phototherapyforherpes.com and fill out the simple registration form.
What this means for the patient is that they can obtain free laboratory testing for their herpes through labcorp of America. This testing can average as high as $140.00 for each test. Since each patient will be tested pre phototherapy protocol and post phototherapy protocol the savings to the patient can average a total of $280.00. Preliminary evidence indicates that individuals that test positive for herpes, and apply the phototherapy protocol to their lesions, along with an herbal protocol, that takes about three weeks to administer, now are testing negative for herpes. Phototherapy wishes to verify this finding in the field with everyday random patients.
To register and receive the free testing for herpes an individual simply needs to follow the following steps:
1. Register at Phototherapyforherpes.com and obtain your treatment kit, a patient ID number and a voucher for testing.
2. Use your voucher to take to the local labcorp and take your pre protocol ELISA test.
3. Return home and apply the phototherapy protocol portion of the kit to your active lesions outbreak.
4. Over the next three weeks use the herbal supplement portion of the kit.
5. Upon completion of the treatment, notify phototherapy and a second voucher will be sent to you within 30 to 45 days. You will then take this voucher to the same lab for the follow up ELISA testing.
6. These results will be sent to phototherapy doctors, and will also be made available to you via email.
This process of pre and post testing, and the data gathered, is a necessary step for phototherapy to present to the FDA for approval to conduct an FDA regulated Investigational New Drug (IND) approved study. More detailed information can be found at Phototherapyforherpes.com.
This preliminary study is limited to the first 250 patients that enroll. The data collected by this study will be posted on our website at Phototherapyforherpes.com.
Look for further information at Phototherapyforherpes.com or call us at 800-996-5161.
# # #